test

Anees B. Chagpar MD, MSc, MA, MPH, MBA, FRCS(C), FACS

Associate Professor of Surgery (Oncology); Director, The Breast Center at Smilow Cancer Hospital at Yale-New Haven; Program Director, Interdisciplinary Breast Fellowship; Assistant Director, Diversity and Health Equity at Yale Cancer Center

Clinical Interests

breast cancer; breast health; ductal carcinoma in situ; invasive breast cancer; inflammatory breast cancer; invasive ductal carcinoma; invasive lobular carcinoma; Paget's disease; lobular carcinoma in situ; atypical hyperplasia; high risk; BRCA; nipple discharge; breast mass; mastectomy; skin-sparing mastectomy; nipple sparing mastectomy; sentinel node biopsy; Mammosite; accelerated partial breast irradiation; minimally invasive breast biopsy; axillary node dissection; lumpectomy; breast conserving surgery; personalized medicine; targeted therapy; hormonal therapy; multidisciplinary care; benign breast disease; fibroadenoma; phylloides tumor


Board Certifications

2004
Surgery, General, Board Certified

Patient Care Locations

anees_chagparfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Breast - Female and Breast - MaleRandomized Phase II trial of Neoadjuvant Cisplatin vs. Doxorubicin/Cyclophosphamide (AC) in Women with Newly Diagnosed Breast Cancer and Germline BRCA Mutations
Breast - FemaleSINGLE ARM, NEOADJUVANT, PHASE II TRIAL OF PERTUZUMAB AND TRASTUZUMAB ADMINISTERED CONCOMITANTLY WITH WEEKLY PACLITAXEL AND FEC FOR CLINICAL STAGE I-III HER2-POSITIVE BREAST CANCER
Cancer and Breast CancerIntra-Operative Specimen Imaging in Breast Cancer Patients Undergoing Standard Partial Mastectomy: A Pilot of the Faxitron BioVision Wedge 3D versus BioVision 2D Imaging
Breast Cancer and CancerExamination of Epigenetic Changes in Breast Tissue and Peripheral Blood of Women at Average versus Increased Risk of Breast Cancer
Breast - FemaleA Pilot Pre-operative Window Trial of Black Cohosh in Women with Ductal Carcinoma in situ

More Clinical Trials...

Edit Profile